Literature DB >> 29301827

Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.

Lotfi Abou-Elkacem1, Huaijun Wang2, Sayan M Chowdhury2, Richard H Kimura2, Sunitha V Bachawal2, Sanjiv S Gambhir2, Lu Tian3, Jürgen K Willmann2.   

Abstract

Purpose: To engineer a dual human and murine Thy1-binding single-chain-antibody ligand (Thy1-scFv) for contrast microbubble-enhanced ultrasound molecular imaging of pancreatic ductal adenocarcinoma (PDAC).Experimental Design: Thy1-scFv were engineered using yeast-surface-display techniques. Binding to soluble human and murine Thy1 and to Thy1-expressing cells was assessed by flow cytometry. Thy1-scFv was then attached to gas-filled microbubbles to create MBThy1-scFv Thy1 binding of MBThy1-scFv to Thy1-expressing cells was evaluated under flow shear stress conditions in flow-chamber experiments. MBscFv-scrambled and MBNon-targeted were used as negative controls. All microbubble types were tested in both orthotopic human PDAC xenografts and transgenic PDAC mice in vivo
Results: Thy1-scFv had a KD of 3.4 ± 0.36 nmol/L for human and 9.2 ± 1.7 nmol/L for murine Thy1 and showed binding to both soluble and cellularly expressed Thy1. MBThy1-scFv was attached to Thy1 with high affinity compared with negative control microbubbles (P < 0.01) as assessed by flow cytometry. Similarly, flow-chamber studies showed significantly (P < 0.01) higher binding of MBThy1-scFv (3.0 ± 0.81 MB/cell) to Thy1-expressing cells than MBscFv-scrambled (0.57 ± 0.53) and MBNon-targeted (0.43 ± 0.53). In vivo ultrasound molecular imaging using MBThy1-scFv demonstrated significantly higher signal (P < 0.01) in both orthotopic (5.32 ± 1.59 a.u.) and transgenic PDAC (5.68 ± 2.5 a.u.) mice compared with chronic pancreatitis (0.84 ± 0.6 a.u.) and normal pancreas (0.67 ± 0.71 a.u.). Ex vivo immunofluorescence confirmed significantly (P < 0.01) increased Thy1 expression in PDAC compared with chronic pancreatitis and normal pancreas tissue.Conclusions: A dual human and murine Thy1-binding scFv was designed to generate contrast microbubbles to allow PDAC detection with ultrasound. Clin Cancer Res; 24(7); 1574-85. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29301827      PMCID: PMC5884723          DOI: 10.1158/1078-0432.CCR-17-2057

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  48 in total

1.  Multiple presentation of Scfv800E6 on silica nanospheres enhances targeting efficiency toward HER-2 receptor in breast cancer cells.

Authors:  Serena Mazzucchelli; Paolo Verderio; Silvia Sommaruga; Miriam Colombo; Agnese Salvadè; Fabio Corsi; Patrizia Galeffi; Paolo Tortora; Davide Prosperi
Journal:  Bioconjug Chem       Date:  2011-10-31       Impact factor: 4.774

Review 2.  Generating improved single-chain Fv molecules for tumor targeting.

Authors:  G P Adams; R Schier
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

3.  Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

Authors:  Max S Topp; Peter Kufer; Nicola Gökbuget; Mariele Goebeler; Matthias Klinger; Svenja Neumann; Heinz-A Horst; Thorsten Raff; Andreas Viardot; Mathias Schmid; Matthias Stelljes; Markus Schaich; Evelyn Degenhard; Rudolf Köhne-Volland; Monika Brüggemann; Oliver Ottmann; Heike Pfeifer; Thomas Burmeister; Dirk Nagorsen; Margit Schmidt; Ralf Lutterbuese; Carsten Reinhardt; Patrick A Baeuerle; Michael Kneba; Hermann Einsele; Gert Riethmüller; Dieter Hoelzer; Gerhard Zugmaier; Ralf C Bargou
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

4.  The human Thy-1 gene: structure and chromosomal location.

Authors:  T Seki; N Spurr; F Obata; S Goyert; P Goodfellow; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results.

Authors:  Jürgen K Willmann; Lorenzo Bonomo; Antonia Carla Testa; Pierluigi Rinaldi; Guido Rindi; Keerthi S Valluru; Gianluigi Petrone; Maurizio Martini; Amelie M Lutz; Sanjiv S Gambhir
Journal:  J Clin Oncol       Date:  2017-03-14       Impact factor: 44.544

Review 6.  Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging.

Authors:  Marybeth A Pysz; Jürgen K Willmann
Journal:  Gastroenterology       Date:  2011-01-18       Impact factor: 22.682

7.  Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies.

Authors:  Veronika Bachanova; Arthur E Frankel; Qing Cao; Dixie Lewis; Bartosz Grzywacz; Michael R Verneris; Celalettin Ustun; Aleksandr Lazaryan; Brian McClune; Erica D Warlick; Hagop Kantarjian; Daniel J Weisdorf; Jeffrey S Miller; Daniel A Vallera
Journal:  Clin Cancer Res       Date:  2015-03-15       Impact factor: 12.531

8.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  Engineered antibody fragments with infinite affinity as reporter genes for PET imaging.

Authors:  Liu H Wei; Tove Olafsen; Caius Radu; Isabel J Hildebrandt; Mark R McCoy; Michael E Phelps; Claude Meares; Anna M Wu; Johannes Czernin; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2008-10-16       Impact factor: 10.057

10.  Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.

Authors:  Lotfi Abou-Elkacem; Katheryne E Wilson; Sadie M Johnson; Sayan M Chowdhury; Sunitha Bachawal; Benjamin J Hackel; Lu Tian; Jürgen K Willmann
Journal:  Theranostics       Date:  2016-06-28       Impact factor: 11.556

View more
  11 in total

1.  Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.

Authors:  Brian M Wolpin; Peter Kraft; Jihye Kim; Chen Yuan; Ana Babic; Ying Bao; Clary B Clish; Michael N Pollak; Laufey T Amundadottir; Alison P Klein; Rachael Z Stolzenberg-Solomon; Pari V Pandharipande; Lauren K Brais; Marisa W Welch; Kimmie Ng; Edward L Giovannucci; Howard D Sesso; JoAnn E Manson; Meir J Stampfer; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-22       Impact factor: 4.254

2.  Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection.

Authors:  Rakesh Bam; Patrick S Lown; Lawrence A Stern; Karina Sharma; Katheryne E Wilson; Gregory R Bean; Amelie M Lutz; Ramasamy Paulmurugan; Benjamin J Hackel; Jeremy Dahl; Lotfi Abou-Elkacem
Journal:  Clin Cancer Res       Date:  2020-01-10       Impact factor: 12.531

Review 3.  Challenges in IBD Research: Novel Technologies.

Authors:  Manish Dhyani; Nitin Joshi; Willem A Bemelman; Michael S Gee; Vijay Yajnik; André D'Hoore; Giovanni Traverso; Mark Donowitz; Gustavo Mostoslavsky; Timothy K Lu; Neil Lineberry; Heiko G Niessen; Dan Peer; Jonathan Braun; Conor P Delaney; Marla C Dubinsky; Ashley N Guillory; Maria Pereira; Nataly Shtraizent; Gerard Honig; David Brent Polk; Andrés Hurtado-Lorenzo; Jeffrey M Karp; Fabrizio Michelassi
Journal:  Inflamm Bowel Dis       Date:  2019-05-16       Impact factor: 5.325

4.  Aptamer-Functionalized Microbubbles Targeted to P-selectin for Ultrasound Molecular Imaging of Murine Bowel Inflammation.

Authors:  Una Goncin; Laura Curiel; C Ronald Geyer; Steven Machtaler
Journal:  Mol Imaging Biol       Date:  2022-07-18       Impact factor: 3.484

Review 5.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; M H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

6.  Validation of Nanoparticle Response to the Sound Pressure Effect during the Drug-Delivery Process.

Authors:  Mohamed Abbas; Mohammed Alqahtani; Ali Algahtani; Amir Kessentini; Hassen Loukil; Muneer Parayangat; Thafasal Ijyas; Abdul Wase Mohammed
Journal:  Polymers (Basel)       Date:  2020-01-10       Impact factor: 4.329

7.  Expression and purification of a native Thy1-single-chain variable fragment for use in molecular imaging.

Authors:  Natacha Jugniot; Rakesh Bam; Ramasamy Paulmurugan
Journal:  Sci Rep       Date:  2021-11-29       Impact factor: 4.379

8.  Theranostic Microbubbles with Homogeneous Ligand Distribution for Higher Binding Efficacy.

Authors:  Simone A G Langeveld; Bram Meijlink; Inés Beekers; Mark Olthof; Antonius F W van der Steen; Nico de Jong; Klazina Kooiman
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

9.  X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma.

Authors:  Hongyu Wang; Xin Li; Lisa A Lai; Teresa A Brentnall; David W Dawson; Kimberly A Kelly; Ru Chen; Sheng Pan
Journal:  Biochimie       Date:  2020-11-23       Impact factor: 4.079

Review 10.  Molecular Imaging and Non-molecular Imaging of Atherosclerotic Plaque Thrombosis.

Authors:  Bingchen Guo; Zhaoyue Li; Peiyang Tu; Hao Tang; Yingfeng Tu
Journal:  Front Cardiovasc Med       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.